Loss of periplakin expression is associated with pathological stage and cancer-specific survival in patients with urothelial carcinoma of the urinary bladder

Biomedical Research (Japan)

Volumn 35, Issue 3, 2014, Pages 201-206

  Matsumoto, Kazumasa ^a   Ikeda, Masaomi ^a   Sato, Yuichi ^a   Kuruma, Hidetoshi ^b   Kamata, Yuko ^b   Nishimori, Takanori ^c   Tomonaga, Tsuyoshi ^d   Nomura, Fumio ^c   Egawa, Shin ^b   Iwamura, Masatsugu ^a  

^a KITASATO UNIVERSITY   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c CHIBA UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MARKER; PERIPLAKIN; PLAKIN; PPL PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; RATING SCALE; RECURRENCE FREE SURVIVAL; TRANSITIONAL CELL CARCINOMA; VERY ELDERLY; CARCINOMA, TRANSITIONAL CELL; FOLLOW UP; GENE EXPRESSION; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RISK; URINARY BLADDER NEOPLASMS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; PLAKINS; PROGNOSIS; URINARY BLADDER NEOPLASMS;

EID: 84902838863     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.35.201     Document Type: Article

References (15)

1. Aho S, Li K, Ryoo Y, McGee C, Ishida-Yamamoto A, Uitto J and Klement J.F (2004) Periplakin gene targeting reveals a constituent of the cornified cell envelope dispensable for normal mouse development. Mol Cell Biol 24, 6410-6418
2. Aho S, McLean W.H, Li K and Uitto J (1998). cDNA cloning, mRNA expression, and chromosomal mapping of human and mouse periplakin genes. Genomics 48, 242-247
3. Aho S, Rothenberger K, Tan E.M, Ryoo Y.W, Cho B.H, McLean W.H and Uitto J (1999) Human periplakin: genomic organization in a clonally unstable region of chromosome 16p with an abundance of repetitive sequence elements. Genomics 56, 160-168
4. Esrig D, Spruck C.H, Nichols P.W, Chaiwun B, Steven K, Groshen S, Chen S.C, Skinner D.G, Jones P.A and Cote R.J (1993). p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol 143, 1389-1397
5. Feng G.J, Kellett E, Scorer C.A, Wilde J, White J.H and Milligan G (2003) Selective interactions between helix VIII of the human mu-opioid receptors and the C terminus of periplakin disrupt G protein activation. J Biol Chem 278, 33400-33407
6. Kazerounian S, Uitto J and Aho S (2002) Unique role for the periplakin tail in intermediate filament association: specific binding to keratin 8 and vimentin. Exp Dermatol 11, 428-438
7. Matsumoto K, Shariat S.F, Ayala G.E, Rauen K.A and Lerner S.P (2005) Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer. Urology 66, 441-446
8. Matsumoto K, Soh S, Satoh T, Iwamura M, Ishikawa Y, Ishii T and Baba S (2008) Distribution of lymphatic vessel network in normal urinary bladder. Urology 72, 706-710
9. Muus Ubago J, Mehta V, Wojcik E.M and Barkan G.A (2013) Evaluation of atypical urine cytology progression to malignancy. Cancer Cytopathol 121, 387-391
10. Nishimori T, Tomonaga T, Matsushita K, Oh-Ishi M, Kodera Y, Maeda T, Nomura F, Matsubara H, Shimada H and Ochiai T (2006) Proteomic analysis of primary esophageal squamous 206 K. Matsumoto et al. cell carcinoma reveals downregulation of a cell adhesion protein, periplakin. Proteomics 6, 1011-1018
11. Okusa H, Kodera Y, Oh-Ishi M, Minamida S, Tsuchida M, Kavoussi P.K, Matsumoto K, Satoh T, Iwamura M, Maeda T and Baba S (2008) Searching for new biomarkers of bladder cancer based on proteomics analysis. J Electrophoresis 52, 19-24
12. Ruhrberg C, Hajibagheri M.A, Parry D.A and Watt F.M (1997) Periplakin, a novel component of cornified envelopes and desmosomes that belongs to the plakin family and forms complexes with envoplakin. J Cell Biol 139, 1835-1849
13. Ruhrberg C and Watt F.M (1997) The plakin family: versatile organizers of cytoskeletal architecture. Curr Opin Genet Dev 7, 392-397
14. Shariat S.F, Pahlavan S, Baseman A.G, Brown R.M, Green A.E, Wheeler T.M and Lerner S.P (2001) E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder. Urology 57, 60-65
15. Simon M and Green H (1984) Participation of membraneassociated proteins in the formation of the cross-linked envelope of the keratinocyte. Cell 36, 827-834.